UZ Leuven
Leuven, Vlaams-Brabant, 3000 Leuven, Belgium
NCT Number: NCT01840202
Glaucoma is a leading cause of blindness worldwide, whose treatment - intraocular pressure lowering - is only partially effective in preventing disease progression. Accordingly, other variables, such as ocular blood flow-related factors, have been implicated in disease pathogenesis. However, most findings involving vascular variables come from partial, small-scale studies. Furthermore, recent technological advances have identified a number of ocular blood flow variables that have yet to be tested in large scale trials. Therefore, a study that specifically aims at uncovering the role of vascular aspects in glaucoma is needed.
For this purpose, a cross-sectional, observational case-control study will be conducted in the University Hospitals Leuven. This will be the largest-yet study on the subject, involving more than 750 patients. This will allow the creation of a specific cohort of patients where the vascular aspects are thought to be particularly important (low-tension glaucoma). It will use the largest combination yet of vascular-related measuring techniques (dynamic contour tonometry, optic coherent tomography, colour Doppler imaging and retinal oximetry)
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Leuven, Vlaams-Brabant, 3000 Leuven, Belgium
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Participants will be followed for the duration of hospital stay, an expected average of 2 hours
Universitaire Ziekenhuizen KU Leuven
Other
Correlation Between Submacular and Peripapillary Choroidal Tissue and Ocular Blood Flow in Glaucoma Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04014933
Eye Diseases, Glaucoma
Zurich, Canton of Zurich, Switzerland
View Trial DetailsNCT04475900
Astigmatism, Corneal Astigmatism
Dresden, Saxony, Germany
View Trial DetailsNCT01802463
Eye Diseases, Glaucoma
Leuven, Flemish Brabant, Belgium
View Trial DetailsNCT00430287
Eye Diseases, Glaucoma
Philadelphia, Pennsylvania, United States
View Trial Details